Publications

  1. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80(12):1133-44. Epub 2013 Feb 20. 2305455
    View PubMed
  2. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013 Jan; 70(1):44-50. 2278838
    View PubMed
  3. Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec; 69(12):1598-607. 2278825
    View PubMed
  4. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, Klassen B, Stead M, Fields JA, Frye MA. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):102-10. 2238269
    View PubMed
  5. Hassan A, Ahlskog JE, Rodriguez M, Matsumoto JY. Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study. Eur J Neurol. 2012 May; 19(5):764-8. Epub 2012 Jan 17. 2218033
    View PubMed
  6. Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry. 2012 Apr; 83(4):453-9. Epub 2012 Jan 06. 2230334
    View PubMed
  7. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69(2):230-8. 2224224
    View PubMed
  8. Savica R, Kumar N, Ahlskog JE, Josephs KA, Matsumoto JY, McKeon A. Parkinsonism and dropped head: dystonia, myopathy or both? Parkinsonism Relat Disord. 2012 Jan; 18(1):30-4. Epub 2011 Aug 27. 2187828
    View PubMed
  9. Savica R, Grossardt BR, Bower JH, Klassen BT, Matsumoto JY. Clinical failure of botulinum toxin A in movement disorders. Parkinsonism Relat Disord. 2012 Jan; 18(1):73-5. Epub 2011 Aug 30. 2187789
    View PubMed
  10. Savica R, Matsumoto JY, Josephs KA, Ahlskog JE, Stead M, Lee KH, Klassen BT. Deep brain stimulation in benign tremulous parkinsonism. Arch Neurol. 2011 Aug; 68(8):1033-6. 2181953
    View PubMed
  11. Czarnecki K, Jones DT, Burnett MS, Mullan B, Matsumoto JY. SPECT perfusion patterns distinguish psychogenic from essential tremor. Parkinsonism Relat Disord. 2011 Jun; 17(5):328-32. Epub 2011 Feb 12. 2147533
    View PubMed
  12. Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord. 2011 May; 17(4):260-4. Epub 2011 Feb 09. 2147579
    View PubMed
  13. Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE. Corrigendum to "Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies" [Parkinsonism Relat Disord 17 (2011) 260-264]. Parkinsonism Relat Disord. 2011; 17(6):499. 2176642
  14. Schiefer TK, Matsumoto JY, Lee KH. Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci. 2011; 5:69. Epub 2011 Nov 09. 2206834
    View PubMed
  15. Schiefer TK, Matsumoto J, Lee KH. Moving forward: Advances in the treatment of movement disorders with deep brain stimulation. Frontiers in Integrative Neuroscience. 2010 Nov; 5:69. 2221597
  16. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15. 2114825
    View PubMed
  17. Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN. Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia. Pediatr Neurol. 2010 Jul; 43(1):46-8. 2109259
    View PubMed
  18. McKeon A, Ahlskog JE, Bower JH, Josephs KA, Matsumoto JY. Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease. Mov Disord. 2009 Jan 15; 24(1):72-6. 1915580
    View PubMed
  19. McKeon A, Matsumoto JY, Bower JH, Ahlskog JE. The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat Disord. 2008 Dec; 14(8):613-9. Epub 2008 Mar 07. 1915927
    View PubMed
  20. McKeon A, Ahlskog JE, Matsumoto JY. Psychogenic tremor occurring after deep brain stimulation surgery for essential tremor. Neurology. 2008 Apr 15; 70(16 Pt 2):1498-9. 1877091
    View PubMed
  21. Glass GA, Ahlskog JE, Matsumoto JY. Orthostatic myoclonus: a contributor to gait decline in selected elderly. Neurology. 2007 May 22; 68(21):1826-30. 1824561
    View PubMed
  22. Elble RJ, Pullman SL, Matsumoto JY, Raethjen J, Deuschl G, Tintner R, Tremor Research Group. Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain. 2006 Oct; 129(Pt 10):2660-6. Epub 2006 Aug 03. 1968768
    View PubMed
  23. Josephs KA, Matsumoto JY, Ahlskog JE. Benign tremulous parkinsonism. Arch Neurol. 2006 Mar; 63(3):354-7. 1754342
    View PubMed
  24. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005 Sep; 11(6):381-6. 2194047
    View PubMed
  25. Josephs KA, Uchikado H, McComb RD, Bashir R, Wszolek Z, Swanson J, Matsumoto J, Shaw G, Dickson DW. Extending the clinicopathological spectrum of neurofilament inclusion disease. Acta Neuropathol (Berl) 2005 Apr; 109(4):427-32. 1720360
    View PubMed
  26. Josephs KA, Matsumoto JY, Lindor NM. Heterozygous Niemann-Pick disease type C presenting with tremor. Neurology. 2004 Dec 14; 63(11):2189-90. 1677623
    View PubMed
  27. Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord. 2004 Dec; 19(12):1482-5. 1677685
    View PubMed
  28. Gabriel DA, Matsumoto JY, Davis DH, Currier BL, An KN. Multidirectional neck strength and electromyographic activity for normal controls. Clin Biomech. 2004 Aug; 19(7):653-8. 1662257
    View PubMed
  29. Hardesty DE, Maraganore DM, Matsumoto JY, Louis ED. Increased risk of head tremor in women with essential tremor: Longitudinal data from the Rochester epidemiology project. Mov Disord. 2004 May; 19(5):529-33. 1645409
    View PubMed
  30. Mokri B, Ahlskog JE, Fulgham JR, Matsumoto JY. Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. Neurology. 2004 Mar 23; 62(6):971-3. 1641256
    View PubMed
  31. Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003 Jul 8; 61(1):40-5. 1404307
    View PubMed
  32. Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, Swenson MA, McClelland RL, Davis DH. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg. 2003 Jun; 98(6):1247-54. 1396743
    View PubMed
  33. Matsumoto J, Morrow D, Kaufman K, Davis D, Ahlskog JE, Walker A, Sneve D, Noseworthy J, Rodriguez M. Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology. 2001 Nov 27; 57(10):1876-82. 1006925
    View PubMed
  34. Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, Dubinsky RM, Friedman JH, Manyam BV, Matsumoto JY, Pullman SL, Rajput AH, Sethi KD, Tanner C, Koller WC. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001 Jun 12; 56(11):1523-8. 1005198
    View PubMed
  35. Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve. 2000 Nov; 23(11):1752-6. 1012787
    View PubMed
  36. Keegan MT, Flick RP, Matsumoto JY, Davis DH, Lanier WL. Anesthetic management for two-stage computer-assisted, stereotactic thalamotomy in a child with Hallervorden-Spatz Disease. J Neurosurg Anesthesiol. 2000 Apr; 12(2):107-11. 131589
    View PubMed
  37. Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord. 1999 Nov; 14(6):940-6. 1009598
    View PubMed
  38. Rubin DI, Matsumoto JY, Suarez GA, Auger RG. Facial trigeminal synkinesis associated with a trigeminal schwannoma. Neurology. 1999 Aug 11; 53(3):635-7. 1008880
    View PubMed
  39. O'Suilleabhain PE, Lagerlund TD, Matsumoto JY. Cortical potentials at the frequency of absolute wrist velocity become phase-locked during slow sinusoidal tracking movements. Exp Brain Res. 1999 Jun; 126(4):529-35. 1008660
    View PubMed
  40. Matsumoto JY, Dodick DW, Stevens LN, Newman RC, Caskey PE, Fjerstad W. Three-dimensional measurement of essential tremor. Mov Disord. 1999 Mar; 14(2):288-94. 1011279
    View PubMed
  41. Warner MA, Warner DO, Matsumoto JY, Harper CM, Schroeder DR, Maxson PM. Ulnar neuropathy in surgical patients. Anesthesiology. 1999 Jan; 90(1):54-9. 109076
    View PubMed
  42. O'Suilleabhain PE, Matsumoto JY. Time-frequency analysis of tremors. Brain. 1998 Nov; 121(Pt 11):2127-34. 1019201
    View PubMed
  43. Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease. Mov Disord. 1998 Sep; 13(5):782-7. 1018961
    View PubMed
  44. Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. Intranasal apomorphine rescue therapy for parkinsonian "off" periods. Clin Neuropharmacol. 1996 Jun; 19(3):193-201. 1025643
    View PubMed
  45. Silbert PL, Matsumoto JY, McManis PG, Stolp-Smith KA, Elliott BA, McEvoy KM. Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology. 1995 Oct; 45(10):1893-7. 94075
    View PubMed
  46. Deuschl G, Toro C, Matsumoto JY, Hallett M. Movement-Related Cortical Potentials in Writer's Cramp. Annals of Neurology. 1995; 38:862-8. 1224245
    View PubMed
  47. Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline. Arch Neurol. 1994 Dec; 51(12):1236-41. 1033301
    View PubMed
  48. Matsumoto JY, Caviness JN, McEvoy KM. The acoustic startle reflex in stiff-man syndrome. Neurology. 1994 Oct; 44(10):1952-5. 1033290
    View PubMed
  49. Dewey RB Jr, Maraganore DM, Matsumoto JY. Posttraumatic cervical dystonia manifesting as isolated spasm of the middle scalene muscle. Mayo Clin Proc. 1994 Feb; 69(2):187-8. 1033235
    View PubMed
  50. Lieberman A, Imke S, Muenter M, Wheeler K, Ahlskog JE, Matsumoto JY, Maraganore DM, Wright KF, Schoenfelder J. Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. Neurology. 1993 Oct; 43(10):1981-4. 1029611
    View PubMed
  51. Basford JR, Hallman HO, Matsumoto JY, Moyer SK, Buss JM, Baxter GD. Effects of 830 nm continuous wave laser diode irradiation on median nerve function in normal subjects. Lasers in Surgery & Medicine. 1993; 13(6):597-604. 1029648
    View PubMed
  52. Toro C, Matsumoto JY, Deuschl G, Roth BJ, Hallett M. Source Analysis of Scalp-Recorded Movement-Related Electrical Potentials. Electroencephalography and Clinical Neurophysiology. 1993; 86:167-75. 1224244
    View PubMed
  53. Matsumoto J, Fuhr P, Nigro M, Hallett M. Physiological abnormalities in hereditary hyperekplexia. Ann Neurol. 1992 Jul; 32(1):41-50. 1224235
    View PubMed
  54. Matsumoto JY, O'Neill BP, Piepgras DG, Scheithauer B. Metastatic malignant glioma with resultant extradural compression of a sacral nerve root. J Neurooncol. 1987; 4(3):227-31. 1055311
    View PubMed
  55. Howard FM, Lennon VA, Finely J, Matsumoto JY, Elveback LR. Correlations of Antibodies that Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravis. Ann NY Academy of Sci. 1986. 1224227
  56. Indrelie JA, Wilson WR, Matsumoto JY, Geraci JE, Washington JA 2nd. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents & Chemotherapy. 1984 Dec; 26(6):909-12. 52979
    View PubMed
  57. Wright AJ, Wilson WR, Matsumoto JY, Washington JA 2nd, Geraci JE. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis. Antimicrobial Agents & Chemotherapy. 1982 Dec; 22(6):972-5. 46714
    View PubMed
  58. Matsumoto JY, Wilson WR, Wright AJ, Geraci JE, Washington JA II. Synergy of penicillin and decreasing concentrations of aminoglycosides against enterococci from patients with infective endocarditis. Antimicrob Agents Chemother. 1980 Dec; 18:944-947. 41079
    View PubMed